Skip to content

Pazopanib Impurity 15

Pazopanib Impurity 15

Product Description
CAT No.
ALN-P013023
CAS No.
1821666-73-2
Mol. F.
C21H23N7O3S
Mol. Wt.
453.5
Stock
Please Inquire
Chemical Name : N,2,3-trimethyl-N-(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)-2H-indazol-6-amine oxide
Smiles : CC1=C(S(=O)(N)=O)C=C(NC2=NC([N+](C)([O-])C3=CC4=NN(C)C(C)=C4C=C3)=CC=N2)C=C1
Inchi : InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1/i1D3,2D3

Analytical control of process impurities in Pazopanib hydrochloride by impurity fate mapping

Yan Li 1, David Q Liu, Shawn Yang, Ravinder Sudini, Michael A McGuire, Dharmesh S Bhanushali, Alireza S KordnJ Pharm Biomed Anal. 2010 Aug 1;52(4):493-507.

Determination and characterization of process impurities in pazopanib hydrochloride drug substance

musty sharada, ravichandra babu – Int J Pharm Pharm Sci, Vol 8, Issue 4, 97-102

Characterization of forced degradation products of pazopanib hydrochloride by UHPLC?Q?TOF/MS and in silico toxicity prediction

Prinesh N. Patel\xa0 Pradipbhai D. Kalariya\xa0 Mahesh Sharma\xa0 Prabha Garg\xa0 M. V. N Kumar Talluri\xa0 S. Gananadhamu\xa0 R. Srinivas – Journal of mass spectrometry Volume50, Issue7 July 2015 Pages 918-928

Request For Quotation